DOJ Closing Abbott Labs Case Spurs Wider Corporate Crime Retreat
Summary
Bloomberg Law reports that the DOJ closed the Abbott Laboratories case, signaling a broader pullback in corporate criminal prosecutions related to health and safety. The decision follows internal reorganizations and a shift toward civil remedies under the False Claims Act, raising questions about enforcement priorities and accountability for consumer health violations.